Glucoprivic regulation of estrous cycles in the rat.
Previous research has shown that glucoprivation induced by chronic 2-deoxy-D-glucose (2DG) treatment extends estrous cycle length and disrupts reproductive behaviors in female hamsters, similar to food deprivation. Such treatment also suppresses food intake, which is reversed in male rats by reducing brain histamine levels prior to 2DG treatment. We, therefore, determined if 2DG extends estrous cycles in the female rat and if this is due to elevated brain histamine levels. We measured estrous cycle length during 2DG-induced glucoprivation, in the presence and absence of alpha-fluoromethylhistidine (FMH), a treatment that reduces brain histamine levels. Adult female rats were treated for 72 h with either saline (n = 8), 2DG (200 mg/kg S.C. every 6 h; n = 9), or FMH (100 mg/kg i.p. daily) + 2DG (200 mg/kg; n = 7). An additional group was treated with FMH (100 mg/kg i.p.; n = 5) alone. To determine if 2DG extends estrous cycles due to glucoprivation or to decreased caloric intake, a group of rats (n = 7) received a reduced diet equal to the mean daily food intake of rats receiving 2DG alone. 2DG induced more long estrous cycles compared to rats receiving saline, FMH + 2DG, or FMH alone. In rats treated with FMH + 2DG, the percentage of 4-5-day cycles was similar to that of saline-treated rats, and a high percentage of 4-5-day cycles was also observed in rats receiving a reduced diet. These data suggest that 2DG does not suppress estrous cycles through a decrease in total calorie intake, but rather by inducing glucoprivation. In addition, during 2DG-induced glucoprivation, elevated brain histamine levels contribute to the mechanism that suppresses reproductive function.
I'Anson
Helen
H
Department of Biology, Washington and Lee University, Lexington, VA 24450, USA. hianson@wlu.edu
Starer
Christine A
CA
Bonnema
Kristen R
KR
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D001835:Body Weight / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D003847:Deoxyglucose / Q000494:pharmacology; D004032:Diet; D002149:Energy Intake / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D030762:Estrous Cycle / Q000502:physiology*; D005260:Female; D005508:Food Deprivation / Q000502:physiology; D005947:Glucose / Q000172:deficiency*; D006632:Histamine / Q000378:metabolism; D008762:Methylhistidines / Q000494:pharmacology; D051381:Rats; D020318:Rats, Long-Evans; D014621:Vagina / Q000166:cytology / Q000187:drug effects
D000963:Antimetabolites; D004791:Enzyme Inhibitors; D008762:Methylhistidines; C028309:alpha-fluoromethylhistidine; D006632:Histamine; D003847:Deoxyglucose; D005947:Glucose